Jason Laine

New CBD Capsule Trial Offers Hope for Insomniacs 0
- CANNABIS OIL
- August 11, 2024
A groundbreaking clinical trial in Australia is exploring the potential of a new CBD-based capsule to combat insomnia. Conducted by Melbourne biotech company Avecho, the trial seeks to recruit 519 participants suffering from episodic insomnia—sleep disturbances lasting one to three months. The capsule, taken once daily before bed, contains cannabidiol (CBD), a compound known for
READ MORE
Alabama’s Medical Marijuana Program Faces Delays, Patients Left Waiting 0
- MEDICAL MARIJUANA
- August 7, 2024
In 2021, Alabama took a significant step by approving a medical marijuana program, promising relief for patients with qualifying conditions. However, three years later, patients are still waiting for access to cannabis products. The delays have been attributed to bureaucratic hurdles and regulatory challenges that have slowed the program’s implementation. Despite the initial optimism, the
READ MORE

Missouri Implements Ban on Delta-8 THC and Other Hemp-Derived Intoxicants 0
- CANNABIS OIL
- August 4, 2024
In a decisive move to safeguard public health, Missouri has announced a ban on the sale of Delta-8 THC and other hemp-derived intoxicants, effective September 1. This prohibition targets products such as drinks, candy, and other edibles infused with these substances, which have surged in popularity but remain largely unregulated. State officials expressed concerns over
READ MORE
Arkansas Medical Marijuana Expansion Effort Gains Extra Time for Signature Collection 0
- MEDICAL MARIJUANA
- July 31, 2024
In a significant development for medical marijuana advocates in Arkansas, state officials have granted an additional 30 days for the collection of signatures to support a ballot initiative aimed at expanding the state’s medical cannabis program. The campaign, led by Arkansans for Patient Access (APA), initially submitted nearly 110,000 signatures but fell short of the
READ MORE